The U.S. Food and Drug Administration has requested additional data from Telix Pharmaceuticals on its application for a ...

Wolters Kluwer ELM Solutions today announced the introduction of new analytics functionality for TyMetrix360°. Leveraging the functionality of Microsoft's Power BI, TyMetrix360° Analytics provides ...

Q1 2025 Earnings Call Transcript August 21, 2025 Telix Pharmaceuticals Limited misses on earnings expectations. Reported EPS is $-0.0068 EPS, expectations were $0.214. Operator: Thank you for standing ...